Efficacy of telmisartan to slow growth of small abdominal aortic aneurysms: a randomized clinical trial
J Golledge, J Pinchbeck, SM Tomee… - JAMA …, 2020 - jamanetwork.com
Importance Currently there is no drug therapy for abdominal aortic aneurysm (AAA).
Objective To test the efficacy of the angiotensin receptor blocker telmisartan in slowing AAA
growth in the Telmisartan in the Management of Abdominal Aortic Aneurysm (TEDY) trial.
Design, Setting, and Participants A randomized, double-blind, placebo-controlled trial
recruited participants between September 6, 2011, and October 5, 2016, to evaluate the
efficacy of telmisartan treatment in patients with AAA. Participants with 35-to 49-mm AAAs …
Objective To test the efficacy of the angiotensin receptor blocker telmisartan in slowing AAA
growth in the Telmisartan in the Management of Abdominal Aortic Aneurysm (TEDY) trial.
Design, Setting, and Participants A randomized, double-blind, placebo-controlled trial
recruited participants between September 6, 2011, and October 5, 2016, to evaluate the
efficacy of telmisartan treatment in patients with AAA. Participants with 35-to 49-mm AAAs …
[PDF][PDF] Efficacy of Telmisartan to Slow Growth of Small Abdominal Aortic Aneurysms A Randomized Clinical Trial
JV Moxon, JS Jenkins, JH Lindeman… - 2020 - scholarlypublications …
OBJECTIVE To test the efficacy of the angiotensin receptor blocker telmisartan in slowing
AAA growth in the Telmisartan in the Management of Abdominal Aortic Aneurysm (TEDY)
trial. DESIGN, SETTING, AND PARTICIPANTS A randomized, double-blind, placebo-
controlled trial recruited participants between September 6, 2011, and October 5, 2016, to
evaluate the efficacy of telmisartan treatment in patients with AAA. Participants with 35-to 49-
mm AAAs recruited from Australia, the Netherlands, and the US were randomized 1: 1 to …
AAA growth in the Telmisartan in the Management of Abdominal Aortic Aneurysm (TEDY)
trial. DESIGN, SETTING, AND PARTICIPANTS A randomized, double-blind, placebo-
controlled trial recruited participants between September 6, 2011, and October 5, 2016, to
evaluate the efficacy of telmisartan treatment in patients with AAA. Participants with 35-to 49-
mm AAAs recruited from Australia, the Netherlands, and the US were randomized 1: 1 to …
以上显示的是最相近的搜索结果。 查看全部搜索结果